Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Long-Term Debt Repayments (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Long-Term Debt Repayments for 9 consecutive years, with $1.0 billion as the latest value for Q1 2025.

  • On a quarterly basis, Long-Term Debt Repayments rose 6800.0% to $1.0 billion in Q1 2025 year-over-year; TTM through Dec 2025 was $1.0 billion, a 6800.0% increase, with the full-year FY2025 number at $1.0 billion, up 6800.0% from a year prior.
  • Long-Term Debt Repayments was $1.0 billion for Q1 2025 at Acadia Healthcare Company, up from $15.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $1.0 billion in Q1 2025 to a low of $10.0 million in Q1 2022.
  • A 5-year average of $169.4 million and a median of $35.0 million in 2021 define the central range for Long-Term Debt Repayments.
  • Peak YoY movement for Long-Term Debt Repayments: crashed 96.3% in 2022, then skyrocketed 6800.0% in 2025.
  • Acadia Healthcare Company's Long-Term Debt Repayments stood at $60.0 million in 2021, then tumbled by 83.33% to $10.0 million in 2022, then skyrocketed by 50.0% to $15.0 million in 2023, then changed by 0.0% to $15.0 million in 2024, then surged by 6800.0% to $1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Long-Term Debt Repayments are $1.0 billion (Q1 2025), $15.0 million (Q1 2024), and $15.0 million (Q3 2023).